0001567619-19-017520.txt : 20190823 0001567619-19-017520.hdr.sgml : 20190823 20190823160806 ACCESSION NUMBER: 0001567619-19-017520 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190821 FILED AS OF DATE: 20190823 DATE AS OF CHANGE: 20190823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rousseau Raphael CENTRAL INDEX KEY: 0001754287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 191049214 MAIL ADDRESS: STREET 1: C/O GRITSTONE ONCOLOGY, INC. STREET 2: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone Oncology, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc1.xml FORM 4 X0306 4 2019-08-21 0 0001656634 Gritstone Oncology, Inc. GRTS 0001754287 Rousseau Raphael C/O GRITSTONE ONCOLOGY, INC. 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 0 1 0 0 See Remarks Common Stock 2019-08-21 4 M 0 10000 0.76 A 10000 D Common Stock 2019-08-21 4 S 0 10000 10.7631 D 0 D Stock Option (Right to Buy) 0.76 2019-08-21 4 M 0 10000 0 D 2018-04-17 2027-05-17 Common Stock 10000 155326 D Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $10.71 to $10.87 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. The stock option vests and becomes exercisable with respect to 25% of the total number of shares on April 17, 2018. The remaining shares vest and become exercisable in equal monthly installments over the following 36 months. Executive Vice President and Chief Medical Officer /s/ Dana B. Johnson, Attorney-in-Fact for Raphael Rousseau 2019-08-23